Dr. Susan W. Benzie, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5565 Hwy. 210, Cromwell, MN 55726 Phone: 218-644-3838 Fax: 218-644-3067 |
Dr. Shawn F Bode, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5568 Clark Avenue, Suite 1, Cromwell, MN 55726 Phone: 218-644-3811 Fax: 218-644-3813 |
Dr. Kelly J. Goeb, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5565 Highway 210, Cromwell, MN 55726 Phone: 320-245-2250 Fax: 320-245-2555 |
News Archive
Millions of middle-aged and older men experience the symptoms of an enlarged prostate multiple times during the day and night. What they may not know is that the disease known as BPH (benign prostatic hyperplasia), marked by urgency and frequent urination, is not one but at least a pair of disorders, and that one of the pair - tied to a newly identified gene - has far more serious implications.
A new patient protocol for aggressive and recurrent lymphoma that combines intensive chemotherapy and radioimmunotherapy (RIT) may become the most powerful cancer-killing therapy available, with the hope that patients' lymphoma can be eradicated as they prepare for bone marrow transplant, say researchers at the 2013 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging.
iBio, Inc. today announced issuance of a US patent covering compositions of matter and methods of use of modified lichenase B polypeptides comprising the Company's iBioModulator platform.
In a paper published today in Nature Communications, an international group of collaborators led by researchers at UPMC Children's Hospital of Pittsburgh have identified a genetic cause of a rare neurological disorder marked by developmental delay and loss of coordination, or ataxia.
Roche announced today it has licensed its P2X3 receptor program aimed at developing first-in-class treatments for chronic pain to Afferent Pharmaceuticals. Afferent was co-founded by Anthony Ford, Ph.D., Pappas Ventures, and Third Rock Ventures, and is focused on developing compounds that treat chronic pain by targeting a novel biological pathway.
› Verified 8 days ago